NEW YORK--(BUSINESS WIRE)--Bristol-Myers
Squibb Company (NYSE:BMY) will take part in the Morgan Stanley 2018
Global Health Care Conference on Thursday, September 13, 2018, in New
York. Giovanni
Caforio, M.D., chairman and chief executive officer will make formal
remarks about the company and answer questions at 11:10 a.m. EDT.
Investors and the general public are invited to listen to a live webcast
of the session at http://investor.bms.com.
Materials related to the presentation will be available at the same
website at the start of the live webcast. An archived edition of the
session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.
